Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
about
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma.Novel systemic therapy against malignant pleural mesothelioma.Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters.Malignant pleural mesothelioma: an update on diagnosis and treatment options.Chemotherapy and targeted therapies for unresectable malignant mesotheliomaThe effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma.First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesotheliomaImproved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Malignant pleural mesothelioma: current treatments and emerging drugs.Surgery for malignant pleural mesothelioma.Management of malignant pleural mesothelioma-The European experience.Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study.Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.Current chemotherapy strategies in malignant pleural mesothelioma
P2860
Q33414357-66E856D4-E4CC-4A69-A572-4741453FC575Q33812537-39BA5D98-C2E6-42AE-964A-5234B6E0ADFDQ33890499-0D0FCB72-5BA9-46D2-8DBC-86AE607CD772Q34178486-66FFA0F7-B037-4673-8050-8F97D224A7E3Q34513958-E2E89249-F0CA-4BF8-B598-2A0629C71203Q35141369-5E84B194-FE0E-48C0-BCF6-F57DBF05AFEAQ35686558-BED84534-086C-4744-B3A8-AE7F6646AF6AQ35832320-04F460F1-0F94-425C-90AB-26A8647358A4Q36097706-766987C0-8B66-4AEE-A7A6-79A624C6B8E6Q36322368-F813701E-2A44-433A-B436-9B8923EC6C75Q37243005-5F53E6BB-6EE0-4627-A53E-E4D5FFADF839Q37529848-F23C95F3-3924-4B5D-BA8D-4961019AD06FQ37762833-CC10C5E5-5B6B-4627-8663-F3AE2C89F69FQ38215513-1345F2A5-F94A-4DAE-BDF3-DBB77399CD58Q43466291-0B103FAD-BB81-4E7F-A29E-80176E63638CQ50665635-28C706F7-9E37-4D3D-AF76-43E312C50CF9Q52672893-0E6E33C9-5DE4-47E1-87B5-DA114C46A65DQ59132464-2EE52033-8D2C-4073-8CA3-A8525A17F883
P2860
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@en
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@nl
type
label
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@en
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@nl
prefLabel
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@en
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@nl
P2093
P1476
Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
@en
P2093
Alberto Muzio
Bruno Castagneto
Diego Dongiovanni
G Sinaccio
Gianmauro Numico
Mario Botta
Sergio Bretti
Silvia Zai
P304
P356
10.1097/01.COC.0000144852.75613.56
P577
2005-06-01T00:00:00Z